39
Participants
Start Date
August 31, 2005
Primary Completion Date
December 31, 2005
Treatment A
Ritobegron Cl (KUC 7483 CL) tablets low dose
Treatment B
Treatment C
Treatment D
Placebo
Moxifloxacin
Lead Sponsor
Boehringer Ingelheim
INDUSTRY